In addition, some specific biomarkers (such as peritoneal HPV-DNA, CEA, SCC-Ag, CD44) are helpful to identify early cervical cancer, make the best treatment plan for patients and improve the prognosis [14, 15]. This evidence concerns the gene CD44 and cervical cancer.